A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
Background. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplas...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Obstetrics and Gynecology |
Online Access: | http://dx.doi.org/10.1155/2013/492754 |
id |
doaj-638b7ccefee7470da8f7f01ae1f32c1f |
---|---|
record_format |
Article |
spelling |
doaj-638b7ccefee7470da8f7f01ae1f32c1f2020-11-25T01:28:25ZengHindawi LimitedCase Reports in Obstetrics and Gynecology2090-66842090-66922013-01-01201310.1155/2013/492754492754A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic TumourWan Yu Luk0Michael Friedlander1Royal Hospital for Women, Barker Street, Randwick, NSW 2031, AustraliaGyneacological Cancer Centre, Royal Hospital for Women, Randwick, NSW 2031, AustraliaBackground. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplasia (GTN), respectively. A mixed choriocarcinoma (CC) and epithelioid trophoblastic tumour (ETT) is an extremely rare subgroup of GTN, which is a highly curable but aggressive form of malignancy. Case. We report a case of mixed CC and ETT in a 41-year-old patient who presented with a 2-year history of menorrhagia and fibroid uterus in the absence of previous history of molar pregnancy. She had a 12-year interval between the antecedent pregnancy and presentation. She was treated with intensive regimen of adjuvant chemotherapy, etoposide, methotrexate, and actinomycin-D with etoposide and cisplatin (EMA-EP). She has remained disease free for more than 5 years. Conclusion. This case highlights the importance of considering GTN as one of the differential diagnoses value of β-HCG in patients presented with menorrhagia and growing fibroids.http://dx.doi.org/10.1155/2013/492754 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wan Yu Luk Michael Friedlander |
spellingShingle |
Wan Yu Luk Michael Friedlander A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour Case Reports in Obstetrics and Gynecology |
author_facet |
Wan Yu Luk Michael Friedlander |
author_sort |
Wan Yu Luk |
title |
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour |
title_short |
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour |
title_full |
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour |
title_fullStr |
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour |
title_full_unstemmed |
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour |
title_sort |
fibroid or cancer? a rare case of mixed choriocarcinoma and epithelioid trophoblastic tumour |
publisher |
Hindawi Limited |
series |
Case Reports in Obstetrics and Gynecology |
issn |
2090-6684 2090-6692 |
publishDate |
2013-01-01 |
description |
Background. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplasia (GTN), respectively. A mixed choriocarcinoma (CC) and epithelioid trophoblastic tumour (ETT) is an extremely rare subgroup of GTN, which is a highly curable but aggressive form of malignancy. Case. We report a case of mixed CC and ETT in a 41-year-old patient who presented with a 2-year history of menorrhagia and fibroid uterus in the absence of previous history of molar pregnancy. She had a 12-year interval between the antecedent pregnancy and presentation. She was treated with intensive regimen of adjuvant chemotherapy, etoposide, methotrexate, and actinomycin-D with etoposide and cisplatin (EMA-EP). She has remained disease free for more than 5 years. Conclusion. This case highlights the importance of considering GTN as one of the differential diagnoses value of β-HCG in patients presented with menorrhagia and growing fibroids. |
url |
http://dx.doi.org/10.1155/2013/492754 |
work_keys_str_mv |
AT wanyuluk afibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour AT michaelfriedlander afibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour AT wanyuluk fibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour AT michaelfriedlander fibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour |
_version_ |
1725101831318667264 |